Oertle, S, H Mauron, and PN Villiger. “Inhibition of the TNF-Pathway: Use of Infliximab and Etanercept As Remission-Inducing Agents in Cases of Therapy-Resistant Chronic Inflammatory Disorders”. Swiss Medical Weekly 132, no. 2930 (July 27, 2002): 414–414. Accessed April 19, 2024. https://smw.ch/index.php/smw/article/view/197.